[S,S]-Reboxetine Dose-Range Finding Trial

Completed · Phase 2

Conditions studied: Pain

In brief

The purpose of this study is to determine the effectiveness of different doses of \[S,S\]-Reboxetine in the treatment of chronic pain following a shingles infection

Key facts

Study ID

NCT00288652

Run by

Pfizer

People needed

280

Starts

2006-03-01

Expected to finish

2007-02-01

Last updated by the study team

2011-06-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have pain present for more than 3 months after the healing of shingles skin rash
• Patients at screening must have a score >/=40 mm on the pain visual analogue scale

You may not qualify if…

• Patients with significant renal and hepatic impairment
• Patients with other severe pain, that may impair the self-assessment of the pain due to shingles
• Patients with clinically abnormal electrocardiogram

Where it is running

• Pfizer Investigational Site — Chandler, Arizona, United States
• Pfizer Investigational Site — Mesa, Arizona, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Sun City, Arizona, United States
• Pfizer Investigational Site — Tucson, Arizona, United States
• Pfizer Investigational Site — Hot Springs, Arkansas, United States
• Pfizer Investigational Site — Arcadia, California, United States
• Pfizer Investigational Site — Fullerton, California, United States
• Pfizer Investigational Site — Irvine, California, United States
• Pfizer Investigational Site — Laguna Hills, California, United States
• Pfizer Investigational Site — Loma Linda, California, United States
• Pfizer Investigational Site — Orange, California, United States
• Pfizer Investigational Site — Redondo Beach, California, United States
• Pfizer Investigational Site — Whittier, California, United States
• Pfizer Investigational Site — Boulder, Colorado, United States
• Pfizer Investigational Site — Bradenton, Florida, United States
• Pfizer Investigational Site — Clearwater, Florida, United States
• Pfizer Investigational Site — Fort Myers, Florida, United States
• Pfizer Investigational Site — Holly Hill, Florida, United States
• Pfizer Investigational Site — Hollywood, Florida, United States
• Pfizer Investigational Site — Kissimmee, Florida, United States
• Pfizer Investigational Site — Largo, Florida, United States
• Pfizer Investigational Site — Longwood, Florida, United States
• Pfizer Investigational Site — Melbourne, Florida, United States
• Pfizer Investigational Site — Huntsville, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.